132 related articles for article (PubMed ID: 4152803)
1. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
Kato H; Noguchi Y; Nakao K; Takagi K
Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
[No Abstract] [Full Text] [Related]
2. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
Tachikawa S; Takenaka T
Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
[No Abstract] [Full Text] [Related]
3. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
Noguchi Y; Nakao K; Kato H; Takagi K
Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
[No Abstract] [Full Text] [Related]
4. [Effects of beta receptor blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) on the circulatory system during intubation for general anesthesia].
Kim SY; Miyamoto K; Yoshikawa K
Masui; 1975 Aug; 24(8):780-6. PubMed ID: 240954
[No Abstract] [Full Text] [Related]
5. [Effects of 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol hydrochloride (YB-2) on coronary circulation and and myocardial metabolism].
Takenaka F; Ishihara T; Higuchi M; Hiraki I; Kawagoe T
Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):848-56. PubMed ID: 4144773
[No Abstract] [Full Text] [Related]
6. Electrophysiologically determined quinidine-like actions of a beta-adrenergic blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2).
Tatsuno H; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):197-207. PubMed ID: 9035
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
Weiss L; Lundgren Y; Folkow B
Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
[No Abstract] [Full Text] [Related]
8. The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.
Baird JR; Linnell J
J Pharm Pharmacol; 1972 Nov; 24(11):880-5. PubMed ID: 4405651
[No Abstract] [Full Text] [Related]
9. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
Caputi AP; Marmo E; Saini RK
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
[No Abstract] [Full Text] [Related]
10. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
Fenyvesi T; George CF; Dollery CT
J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
[No Abstract] [Full Text] [Related]
11. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
Zechel HJ
Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
[No Abstract] [Full Text] [Related]
12. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
Basil B; Jordan R; Loveless AH; Maxwell DR
Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
[No Abstract] [Full Text] [Related]
14. Timolol maleate, a new beta-adrenergic receptor blocking agent.
Hall RA; Robson RD; Share NN
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
[TBL] [Abstract][Full Text] [Related]
15. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
Meyer RF; Stratton CD; Hastings SG; Corey RM
J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
[No Abstract] [Full Text] [Related]
16. Effects of propranolol and a new 'cardioselective' beta-blocker, H 93-26, on responses of isolated rat atria to isoprenaline and noradrenaline.
Johansson B
Eur J Pharmacol; 1973 Nov; 24(2):194-204. PubMed ID: 4148794
[No Abstract] [Full Text] [Related]
17. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents.
Adam KR; Baird JR; Burges RA; Linnell J
Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851
[No Abstract] [Full Text] [Related]
18. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
Masumoto S; Inoue H; Maruyama Y
Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
[No Abstract] [Full Text] [Related]
19. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
Harry JD; Kappagoda CT; Linden RJ; Snow HM
Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
[No Abstract] [Full Text] [Related]
20. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.
Ablad B; Carlsson E; Ek L
Life Sci I; 1973 Feb; 12(3):107-19. PubMed ID: 4144510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
